NUMINUS WELLNESS INC.

Ajouter à une liste

Instrument Inactif

Communiqués Numinus Wellness Inc. Toronto S.E.

Actions

NUMI

CA67054W1032

Recherche biotechnologique et médicale

Communiqués

13/01/25	Numinus Provides Bi-Weekly Update on Annual Filings	PR
01/01/25	Numinus Provides Bi-Weekly Update on Annual Filings	PR
16/12/24	Numinus Provides Bi-Weekly Update on Annual Filings	PR
13/12/23	Numinus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSD	PR
03/10/23	Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research	PR
26/09/23	Numinus Wellness Inc. Announces At-The-Market Offering Equity Program	PR
14/06/23	Numinus Appoints New Chief Financial Officer	PR
05/06/23	Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120	PR
27/03/23	Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training Program	PR
15/02/23	Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders	PR
01/11/22	Numinus Re-Launches "Psychedelic Therapy Frontiers" Podcast with additional hosts and topics	PR
14/07/22	Numinus Wellness Inc. Reports Q3 2022 Results	PR
11/06/22	Numinus completes acquisition of Novamind and announces executive appointments	PR
14/04/22	Numinus Wellness Inc. Reports Q2 2022 Results	PR
01/02/22	Numinus Appoints New Bioscience Advisors to Advance IP Development	PR
20/01/22	Numinus Wellness Inc. Reports Q1 2022 Results	PR
09/12/21	Numinus Wellness Inc. Reports Q4 and Year End 2021 Results	PR
22/11/21	Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021	PR
19/06/17	IIROC Trade Halt - Rojo Resources Ltd.	NE

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Espace mes listes

Palmarès

Suite du Palmarès

Palmarès

Suite du Palmarès

Devises / Forex

Matières Premières

Cryptomonnaies

Taux d'Intérêts

Dès maintenant, trouvez facilement les meilleurs investissements de demain !